Chemoprevention Study of Selenium for Non-Small Cell Lung Cancer (8/9/05)
Lung cancer is responsible for more cancer deaths in America than breast cancer, colon cancer, and prostate cancer combined. In its earliest stages, non-small cell lung cancer (NSCLC) may be removed surgically with potentially curative results. However, the incidence of a second tumor developing in patients who have been treated surgically for early-stage NSCLC is about 20 to 30 percent.
In this study, researchers are investigating the ability of selenium to prevent the development of secondary lung tumors in patients with surgically removed, early-stage NSCLC. Selenium is an essential dietary mineral that has been shown in animal studies to inhibit the growth of tumors. It is also associated with reduced cancer incidence in some animal populations.
Researchers seek to enroll 1,960 patients 18 years of age and older who have had stage I NSCLC completely removed by surgery.
See the list of study contacts or call the NCI's Cancer Information Service at 1-800-4-CANCER (1-800-422-6237). The call is toll free and completely confidential.
To view: http://www.cancer.gov/clinicaltrials/ft-ECOG-5597
|Remember we are NOT Doctors and have NO medical training.|
This site is like an Encyclopedia - there are many pages, many links on many topics.
Support our work with any size DONATION - see left side of any page - for how to donate. You can help raise awareness of CAM.